GENB
Ticker
Generate Biomedicines, Inc.
GENB · Healthcare · Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development throug…Generate Biomedicines, Inc. (GENB), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 3 purchases and 1 sale, 1 filed past the deadline. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Oct 29 and filed Nov 4. The most active filer was Noubar Afeyan with 2 filings. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
4
3 buys · 1 sell · 1 late
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$150.4M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Oct 29
Filed Nov 4
ADViAverage daily dollar volume
$16.9M
market data
Share price · 12M
$13.06 (+3.2%)
Adjusted for splits and dividends.
Volume by month
Buys $150.2M
Sells $185K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
NA
Noubar Afeyan
Director
2 filings · 2 buys, 0 sales
FA
Frances Arnold
Director
1 filing · 0 buys, 1 sale
MN
Michael Nally
Chief Executive Officer
1 filing · 1 buy, 0 sales
Recent filings
Frances ArnoldSALE
Director
$185K11,409 sh × $16.19
Exec Oct 29
Filed Nov 4 · 4:05 PM ET † Michael NallyPURCHASE Chief Executive Officer $240K
20,000 sh × $12.00
Exec Mar 4
Filed Mar 6 · 4:55 PM ET Noubar AfeyanPURCHASE Director $75.0M
4,687,500 sh across 3 lots
Exec Mar 2
Filed Mar 2 · 5:52 PM ET Noubar AfeyanPURCHASE Director $75.0M
4,687,500 sh across 3 lots
Exec Mar 2
Filed Mar 2 · 5:42 PM ET